OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multitargeting the Action of 5-HT6 Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer’s Disease: Can It Work from a Molecular Point of View?
Kinga Czarnota-Łydka, Katarzyna Kucwaj‐Brysz, Patryk Pyka, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8768-8768
Open Access | Times Cited: 5
Kinga Czarnota-Łydka, Katarzyna Kucwaj‐Brysz, Patryk Pyka, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8768-8768
Open Access | Times Cited: 5
Showing 5 citing articles:
Comparative effects of moderate-intensity continuous training and high-intensity interval training on ADHD symptoms and behavioral inhibition in children
Ayoob Sabaghi, Behrooz Ebrahimi, Namdar Yousofvand, et al.
European Journal of Pediatrics (2025) Vol. 184, Iss. 2
Closed Access
Ayoob Sabaghi, Behrooz Ebrahimi, Namdar Yousofvand, et al.
European Journal of Pediatrics (2025) Vol. 184, Iss. 2
Closed Access
Therapeutic targeting of microtubule affinity‐regulating kinase 4 in cancer and neurodegenerative diseases
Manzar Alam, Sarfraz Ahmed, Mohammad Abid, et al.
Journal of Cellular Biochemistry (2023) Vol. 124, Iss. 9, pp. 1223-1240
Open Access | Times Cited: 10
Manzar Alam, Sarfraz Ahmed, Mohammad Abid, et al.
Journal of Cellular Biochemistry (2023) Vol. 124, Iss. 9, pp. 1223-1240
Open Access | Times Cited: 10
Anticholinesterase and Serotoninergic Evaluation of Benzimidazole–Carboxamides as Potential Multifunctional Agents for the Treatment of Alzheimer’s Disease
Daria A. Belinskaia, Polina A. Voronina, Д. В. Криворотов, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2159-2159
Open Access | Times Cited: 3
Daria A. Belinskaia, Polina A. Voronina, Д. В. Криворотов, et al.
Pharmaceutics (2023) Vol. 15, Iss. 8, pp. 2159-2159
Open Access | Times Cited: 3
Predicting biological activity and design of 5-HT6 antagonists through assessment of ANN-QSAR models in the context of Alzheimer’s disease
Daniel S. Sousa, Aldineia P. da Silva, Laise P. A. Chiari, et al.
Journal of Molecular Modeling (2024) Vol. 30, Iss. 10
Closed Access
Daniel S. Sousa, Aldineia P. da Silva, Laise P. A. Chiari, et al.
Journal of Molecular Modeling (2024) Vol. 30, Iss. 10
Closed Access
Stress induced exacerbation of Alzheimer’s disease brain pathology is thwarted by co-administration of nanowired cerebrolysin and monoclonal amyloid beta peptide antibodies with serotonin 5-HT6 receptor antagonist SB-399885
Hari Shanker Sharma, Lianyuan Feng, Dafin F. Mureşanu, et al.
International review of neurobiology (2023), pp. 3-46
Closed Access
Hari Shanker Sharma, Lianyuan Feng, Dafin F. Mureşanu, et al.
International review of neurobiology (2023), pp. 3-46
Closed Access
